617718-45-3 Usage
General Description
1-Benzhydryl-3-fluoroazetidine is a chemical compound belonging to the class of azetidines, organic compounds containing a four-membered ring with three carbon atoms and one nitrogen. The fluorine atom in this chemical introduces unique properties and potential reactivity due to its high electronegativity. 1-benzhydryl-3-fluoroazetidine is specifically characterized by its two-part structure of a benzhydryl group and a fluorinated azetidine group. Benzhydryl refers to the combination of two phenyl rings bound to the same carbon molecule. Although its specific uses or applications are not widely indicated in chemical literature, this compound, like others in its class, could have potential applications in medicinal chemistry or other fields that utilize complex organic structures.
Check Digit Verification of cas no
The CAS Registry Mumber 617718-45-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,1,7,7,1 and 8 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 617718-45:
(8*6)+(7*1)+(6*7)+(5*7)+(4*1)+(3*8)+(2*4)+(1*5)=173
173 % 10 = 3
So 617718-45-3 is a valid CAS Registry Number.
617718-45-3Relevant articles and documents
Alcohol compound-based in-situ deoxygenation fluorination synthesis method and alcohol compound-based F radiolabeling method
-
Paragraph 0043-0045; 0067-0069, (2020/02/14)
The invention discloses an alcohol compound-based in-situ deoxidation fluorination synthesis method and an alcohol compound-based F radiolabeling method. Alkyl alcohols such as 4-phenyl-1-butanol,which are used as raw materials, react with trifluorome
9-AMINOMETHYL SUBSTITUTED TETRACYCLINE COMPOUND
-
Paragraph 0163-0164, (2014/06/24)
The present invention relates to 9-aminomethyl substituted tetracycline compounds represented by formula (I), or pharmaceutically acceptable salt, prodrug, solvate or isomer thereof, as well as a method for preparing these compounds and a pharmaceutical composition comprising the same. The present invention relates also to a use of these compounds in the preparation of a medicament for the treatment and/or prophylaxis of tetracycline drug-sensitive disease. wherein, R2a, R2b, R3, R4a, R4b, R5, R6a, R6b, R7, R8, R9a, R9b, R10, R11, R12, R13a and R13b are each independently as defined in the description.
Fluorinated lysine derivatives as dipeptidyl peptidase IV inhibitors
-
Page/Page column 12, (2008/06/13)
-
